Plant Waste Reuse Industry Technology Innovation Strategic Alliance Established Tianjin Jianfeng Natural Products Company as Chairman Unit Led Formation
Release time:
2020-07-31
News from our newspaper 7# April 13 , the first council of the "Strategic Alliance for Technological Innovation in Plant Waste Reuse Industry" with Tianjin Jianfeng Natural Products Company as its chairman was solemnly held in Tianjin, marking the formal establishment of the alliance.
In order to cope with the new challenges brought about by economic transformation and upgrading, in recent years, Tianjin Economic and Technological Development Zone has continuously adjusted its industrial structure, actively introduced innovation carriers and resources, cultivated new growth points, and grasped the support of technology-based enterprises. Work, with the goal of cultivating a group of high-growth enterprises with innovative characteristics in the new era, making it the pillar of economic development in the development zone and even Binhai New Area and the main force of innovation. 2016 11 , the development zone selected for the first time 20 science and technology enterprises in the zone as demonstration enterprises, of which Tianjin Jianfeng is one, and with the support of relevant policies of Tianjin municipal party Committee and municipal government, in conjunction with Tianjin University of Science and Technology, Tianjin University of Agriculture, Mr. Portugal (Tianjin) Technology Co., Ltd., Tianjin Minsheng Bioengineering Co., Ltd., Tianjin Yibei Red Biotechnology Co., Ltd. and other enterprises and institutions, set up a "strategic alliance for technological innovation in plant waste reuse industry" (hereinafter referred to as "alliance") to carry out cooperative research and development of key technologies for "plant waste reuse" in key health industries, formulate, revise and promote industrial technology standards, and promote another new field of green health industry through the establishment of open sharing of scientific and technological resources and industrial technology information exchange platform.
The convening of the first council of the alliance has received extensive attention from relevant government departments, the media and the industry. Tianjin Science and Technology Commission, Binhai New Area Science and Technology Commission, Tianjin Development Zone Science and Technology Development Bureau and other government departments, Tianjin University of Science and Technology, Tianjin Agricultural College, Nankai University, Tianjin Pharmaceutical Research Institute, Tianjin Food Research Institute and other well-known universities and research institutions in the industry, Tianjin Chinese Herbal Medicine Magazine, Zhitiqiao, China Chamber of Commerce for Import and Export of Medicines and Health Products, China Council for the Promotion of International Trade Chemical Industry Industry Media and organizations, all leaders and experts participated in this event, advise the plant waste reuse industry advocated by Tianjin Jianfeng Natural Products Company.
According to reports, the main research direction of the alliance is the plant waste and by-product resources generated in the food processing process. In the past two decades, Jianfeng Natural Products Company has accumulated rich experience in the efficient extraction and separation technology of active ingredients in natural products such as natural grape seeds, apples, anthocyanins, ginseng, etc., and has established biomedicine, plant extracts, agricultural products, Food processing, and health care products are the most important development links in the industrial chain. After the establishment of the alliance, it will use the regional advantages of Tianjin Economic and Technological Development Zone, universities and enterprises in the joint alliance will "enhance the focus of the industry", enhance the innovation ability of the enterprise itself and the industry itself, and realize the transformation and promotion of key technologies and the linkage of upstream and downstream industries, so as to promote the sustainable development of the biomedical food industry chain.
At this meeting, Liu Dan, general manager of Jianfeng Natural Products Company, proposed a number of research topics currently planned by the alliance, mainly including the further extraction and comprehensive development and utilization of active ingredients in products such as apples, grape seeds and anthocyanins, which received enthusiastic responses from participating enterprises and experts. Tianjin University of Science and Technology said that it will give full play to its technical advantages in food engineering to provide support for the product application of Jianfeng Natural Products Company; as the upstream of the industrial chain, Mr. Portugal (Tianjin) Technology Co., Ltd. will cooperate with natural products companies to carry out the cultivation of new grape varieties and the development of comprehensive utilization industrialization with its advantages in grape variety cultivation; tianjin Minsheng Bioengineering Co., Ltd. will focus on the comprehensive utilization of waste resources. Representatives of Zhiti professional media Zhiti Bridge and several industry associations also said that they would build more platforms to display the outstanding achievements in the industry and promote the process of industrialization.
The establishment of the Industrial Innovation Alliance is the first pilot project initiated by Binhai New Area nationwide. Liu Dan, general manager of Jianfeng natural products company, said that he hoped that through a series of research of the alliance, we could really give full play to the leading role of science and technology demonstration enterprises, extensively carry out peer cooperation, gather superior resources in the industry, develop high-quality plant extract products, promote the upstream and downstream industrial chain to develop in a longer, deeper and broader direction, and launch more industry leading enterprises, And go abroad together, stand on a higher stage to play the strength of China's plant to mention enterprises. (Mu Ruixin, Liu Ying)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31